Barely Significant
← all excerpts

Single dose denileukin diftitox does not enhance vaccine-induced T cell responses or effectively deplete Tregs in advanced melanoma: immune monitoring and clinical results of a randomized phase II trial.

J Immunother Cancer · 2016 · PMC4915048 · PMID 27330808

1
hedged sentence
closest p
boldest claim

The sentences

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.